Ewing's Sarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
Conditions:   Relapsed/Refractory Rhabdomyosarcoma;   Non-rhabdomyosarcoma Soft Tissue Sarcoma;   Ewing Sarcoma Intervention:   Drug: Eribulin mesylate Sponsor:   Eisai Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2018 Category: Research Source Type: clinical trials